Blue Bell Private Wealth Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$436 745
2023
Q4
$436 Hold
12
﹤0.01% 706
2023
Q3
$579 Hold
12
﹤0.01% 654
2023
Q2
$819 Hold
12
﹤0.01% 650
2023
Q1
$582 Hold
12
﹤0.01% 644
2022
Q4
$723 Hold
12
﹤0.01% 657
2022
Q3
$1K Hold
12
﹤0.01% 703
2022
Q2
$0 Hold
12
﹤0.01% 870
2022
Q1
$0 Hold
12
﹤0.01% 913
2021
Q4
$1K Buy
+12
New +$665 ﹤0.01% 803

Other funds holding PRTA

Blue Bell Private Wealth Management's PRTA Position: Q1 2024 in Review

Blue Bell Private Wealth Management sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 12 shares — an estimated $436 sold.

Blue Bell Private Wealth Management first reported a position in PRTA in Q4 2021 and held it in 9 quarters. The position peaked at $1K in Q3 2022. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • Blue Bell Private Wealth Management reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • Blue Bell Private Wealth Management sold 12 Prothena Corp shares in Q1 2024, an estimated $436.
  • Blue Bell Private Wealth Management first reported a position in Prothena Corp in Q4 2021 and held it in 9 quarters.
  • Blue Bell Private Wealth Management's Prothena Corp position peaked at $1K in Q3 2022.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Blue Bell Private Wealth Management's 13F filing for Q1 2024, filed 24 Apr 2024.